We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use tewv.nhs.uk, remember your settings and improve our services.
We also use cookies set by other sites to help us deliver content from their services.
This document gives the guidelines for atomoxetine which is a selective noradrenaline reuptake inhibitor used for the management of ADHD in adults and children.
Follow us on social media for all the latest news and announcements